```html

Juvenile Laryngeal Papillomatosis (JLP)

Overview

Juvenile laryngeal papillomatosis (JLP) is a rare, benign disease in which multiple wart‑like growths (papillomas) develop on the vocal cords and other parts of the airway. Although the tumors are non‑cancerous, they can obstruct airflow, cause hoarseness, and require repeated medical procedures.

• Typical age of onset: Most children are diagnosed before the age of 5, with a peak between 2–3 years.
• Gender distribution: Slight male predominance (≈55 % male, 45 % female).
• Prevalence: Estimated at 0.2–0.3 cases per 1,000 live births in the United States (≈5,000–7,000 children in the U.S. each year)【1】.
• Geographic variation: Higher incidence in regions with lower rates of maternal HPV vaccination.

Symptoms

The clinical picture depends on the size, number, and location of the papillomas. Common and less common symptoms include:

• Hoarseness or a raspy voice – often the first sign.
• Stridor (high‑pitched breathing noise) – may be intermittent or constant.
• Chronic cough – especially a dry cough that worsens with activity.
• Difficulty swallowing (dysphagia) – can lead to gagging or food aversion.
• Respiratory distress – shortness of breath, especially during infections or when papillomas enlarge.
• Recurrent respiratory infections – due to partial airway obstruction.
• Voice fatigue – child tires quickly when speaking or singing.
• Apnea or pauses in breathing during sleep – rare but reported in severe cases.
• Ear pain or recurrent otitis media – can result from eustachian tube involvement.

Causes and Risk Factors

Primary cause

JLP is caused by infection with human papillomavirus (HPV) types 6 and 11, which are low‑risk, mucosal strains. The virus infects the squamous epithelium of the larynx and triggers wart formation.

Transmission pathways

• Perinatal transmission – the most common route; the virus is passed from mother to infant during vaginal delivery (estimated 0.5–2 % of births)【2】.
• Horizontal transmission – rare, through close contact with infected caregivers or siblings.

Risk factors

• Maternal infection with HPV 6 or 11 during pregnancy.
• Delivery by vaginal birth (versus cesarean section) – studies show a 2–3‑fold higher risk.
• Absence of maternal HPV vaccination before pregnancy.
• Maternal smoking or immunosuppression, which may increase viral load.
• Genetic susceptibility: certain HLA types (e.g., HLA‑DRB1*03) have been linked to more aggressive disease.

Diagnosis

Because early symptoms mimic common childhood conditions (e.g., laryngitis), a high index of suspicion is essential.

Clinical evaluation

• Detailed history (onset of hoarseness, birth details, maternal HPV status).
• Physical exam focusing on airway sounds (stridor, harsh breathing).

Instrumental tests

1. Flexible or rigid laryngoscopy – direct visualization of papillomas on the vocal folds; the gold‑standard diagnostic tool.
2. Video stroboscopy – assesses vocal cord vibration and helps plan surgery.
3. Imaging (CT or MRI) – reserved for suspected distal airway involvement or when surgery is planned.

Laboratory tests

• HPV DNA testing (PCR) on a biopsy specimen confirms the viral type.
• If perinatal transmission is suspected, maternal cervical swab for HPV typing may be performed.

Pathology

Biopsy shows exophytic squamous epithelium with koilocytosis (HPV‑related changes) but no dysplasia.

Treatment Options

There is no cure; management focuses on maintaining airway patency, preserving voice, and reducing recurrence.

Surgical interventions

• Microdebridement (cold steel or micro‑laser) – removal of papillomas under microscopy; the most common first‑line treatment.
• CO₂ laser – precise ablation, especially for larger lesions; carries a small risk of airway scar formation.
• Micro‑cautery or plasma – alternative for lesions difficult to excise with laser.
• Tracheostomy – only when airway obstruction is severe and cannot be managed endoscopically.

On average, children require 4–6 procedures per year, though some have fewer and others many more.

Adjunctive medical therapies

1. Intralesional cidofovir – antiviral nucleotide analogue injected into papillomas; may reduce recurrence in refractory cases. Monitoring for renal toxicity is required.
2. Bevacizumab (anti‑VEGF) – used off‑label as an injection or topical spray; early studies show promising reduction in lesion size.
3. Interferon‑α – historically used but limited by systemic side effects.
4. HPV therapeutic vaccines (e.g., VGX‑3100) – clinical trials are ongoing; not yet standard of care.

Systemic considerations

• Prophylactic antibiotics are **not** routinely given; they are used only if a bacterial superinfection is documented.
• Analgesia and anti‑inflammatory medication post‑procedure (acetaminophen or ibuprofen) help comfort the child.

Lifestyle & supportive measures

• Voice rest for 24‑48 hours after surgery.
• Humidified air (cool‑mist humidifiers) to keep the airway moist.
• Avoidance of tobacco smoke and other respiratory irritants.
• Regular follow‑up with an otolaryngologist experienced in pediatric airway disease.

Living with Juvenile Laryngeal Papillomatosis

Daily management tips

• Hydration – encourage water intake; a well‑hydrated mucosa is less prone to irritation.
• Humidified environment – especially in dry climates or during winter heating.
• Voice hygiene – teach children to speak softly, avoid shouting, and use diaphragmatic breathing.
• Nutrition – soft, easy‑to‑swallow foods during flare‑ups; maintain a balanced diet to support immune health.
• School accommodations – allow extra time for oral presentations, limit noisy cafeteria environments, and provide a “quiet space” if needed.
• Psychosocial support – coping with repeated surgeries can be stressful. Referral to a child psychologist or support group is beneficial.

Family considerations

Parents should be educated about the contagious nature of HPV. Though low‑risk types rarely cause disease in healthy adults, good hand hygiene and avoiding sharing utensils during active lesions reduce any theoretical transmission.

Prevention

• Maternal HPV vaccination – The 9‑valent HPV vaccine (covers HPV 6/11) administered before pregnancy reduces the risk of perinatal transmission by up to 80 %【3】.
• Cesarean delivery – May lower transmission risk, but current guidelines recommend it only for obstetric indications.
• Screening & treatment of maternal genital warts – Treating lesions before delivery can decrease viral load.
• Smoking cessation – Reduces maternal viral shedding.
• Good prenatal care – Early identification of HPV infection permits counseling.

Complications

If the disease is not adequately controlled, several serious problems may arise:

• Airway obstruction – leading to chronic hypoxia, respiratory failure, or need for tracheostomy.
• Voice impairment – persistent hoarseness can affect speech development and academic performance.
• Recurrent respiratory papillomatosis (RRP) in the lower airway – rare but can involve the trachea and bronchi, worsening obstruction.
• Malignant transformation – extremely rare (<1 %); occasional progression to squamous cell carcinoma in adulthood, especially with HPV 11 infection.
• Psychological impact – anxiety, depression, or social withdrawal due to voice changes and repeated surgeries.

When to Seek Emergency Care

References

1. Mayo Clinic. “Recurrent Respiratory Papillomatosis.” Updated 2023. https://www.mayoclinic.org/...
2. Centers for Disease Control and Prevention. “HPV and Children.” 2022. https://www.cdc.gov/...
3. World Health Organization. “Human papillomavirus (HPV) vaccines: WHO position paper, May 2022.” https://www.who.int/...
4. Cleveland Clinic. “Recurrent Respiratory Papillomatosis (RRP).” 2024. https://my.clevelandclinic.org/...
5. NIH National Institute of Child Health & Human Development. “HPV Infection and Pregnancy.” 2023. https://www.nichd.nih.gov/...

```